2023-07-03 12:59:16
In fifteen years, France has gone from 1st to 4th place in Europe in terms of pharmaceutical production. Benjamin Nolte / noltemedia/benjaminnolte – stock.adobe.com
ANALYSIS – ANALYSIS – France imports 95% of biological drugs sold in the country. She only makes 3% of the monoclonal antibodies she consumes.
Proud to sell its cheeses, its wines or even its planes abroad, France is exporting less and less of the old medicines it produces, and is importing more and more innovative medicines. This is the cry of alarm from pharmaceutical laboratories established in France. They see it as proof of the loss of momentum of our health industries and of our health dependence. And a risk of seeing drug shortages – which hitherto mainly concerned old products – worsen in the future.
The finding is striking. Of the new drugs having obtained authorization between 2017 and 2022, only 48 are produced on French territory, against 122 in Germany, details the study by the Roland Berger firm commissioned by Leem, which federates drug companies.
In fifteen years, France has gone from 1st to 4th place in Europe in terms of pharmaceutical production. It has been left behind in the production of generics, drugs…
This article is for subscribers only. You have 74% left to discover.
Want to read more?
Unlock all items immediately.
Already subscribed? Login
#worrying #decline #France